CordenPharma: Peptisyntha Acquired from Solvay
International Chemical Investors Group (ICIG) and the Solvay Group, Brussels, Belgium, have entered into an agreement under which ICIG will acquire Peptisyntha SA, Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the deal, expected later this fall, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptides manufacturing.
For Solvay, the divestiture marks another step in focusing on its core industrial activities, and completes the group’s exit from life science activities. As a CordenPharma member company, Peptisyntha will continue to execute its growth strategy, serving a wide range of applications and customers. While the US sister company Peptisyntha Inc., Torrance, California, is not part of the transaction, certain of its customer relationships will be assumed by Peptisyntha in Brussels.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.